▷ What is happening with the AstraZeneca vaccine?

The AstraZeneca vaccine is back in the spotlight. Spain announced that it will suspend the administration of British vaccines for 15 days. After Germany, France and Italy, the way out of the health crisis faces serious obstacles and gradually disappears. The goal is to reach 70% of the vaccinated population in summer.

Data from the Paul Ehrlich Institute in Germany

Data from the Paul Ehrlich Institute in Germany led the AstraZeneca vaccine developed by the University of Oxford to stop vaccination at all ages. According to the statement from the research center, compared to the latest data analysis from last week, more cases of thrombosis have been found in the vaccinated population in Germany.

Although the data has not been disclosed, the agency confirmed that it will continue to investigate, but will be responsible for the European Medicines Agency (EMA, its abbreviation in English is EMA), but at the same time, the AstraZeneca vaccine is no longer regulated in Germany O the first dose or subsequent doses.

In particular, the Paul Ehrlich Institute has observed a significant increase in a special form of cerebral venous thrombosis, which has been described as “very rare” and has set off alarms.

First case of cerebral venous thrombosis in Spain

María Jesús Lamas, director of the Spanish Medical Service, has announced that in Spain cases of cerebral venous thrombosis have been detected this weekend, increasing 4 cases in Norway and 6 cases in Germany. Since these cases are extremely rare, the sum of these cases is decisive to stop vaccination preventively.

Lamas emphasized: “In a total of 17 million people who have been vaccinated, there are 11 cases.” According to Lamas, in the UK, only 3 cases were found out of 10 million doses of vaccine administered.

Thrombosis symptoms to detect risk after vaccination

Suspicious symptoms for the AstraZeneca vaccine are very severe headaches, which can aggravate headaches when lying down, or are accompanied by vomiting, visual disturbances, or irregular bleeding. The Paul Ehrlich Institute cautions that people who experience severe discomfort, persistent headaches, or spotty skin bleeding four days after vaccination should contact their doctor immediately.


For patients who have been vaccinated with AstraZeneca, the Spanish Drug Administration clearly noted that headaches or headaches are common symptoms after vaccination against COVID-19. However, if you have been vaccinated in the last 14 days and the headache is severe and persistent, changes significantly when lying down, or is related to visual impairment or other persistent neurological symptoms, it is recommended that you consult a doctor.

You may also be interested in:

Uncommon thrombosis

According to the Spanish Academy of Neurology, cerebral venous sinus thrombosis is a rare cerebrovascular disease (less than 0.5% of all cerebrovascular diseases that occur in Spain). The incidence is believed to be approximately 1-1.3 cases / 100,000 inhabitants per year.

Although it is more common in women and young patients, it can affect people of any age. According to this scientific society, among the risk factors of a specific sex, oral contraceptives, pregnancy and the use of hormonal therapy are dangerous. Diagnose by neuroimaging (CT and MRI).

The most common venous thrombosis is thrombosis in the lower extremities, but blood clots in the brain are very rare. They are a type of stroke, but very rare strokes. ” what type of thrombosis the vaccine is related to.

After the announcement of the first case of thrombosis last week, the Canary Islands, Asturias, Andalusia and Castilla y León have confirmed their temporary withdrawal from those already in Austria. The dose of the AstraZeneca vaccine, suspected of a thromboembolic event, is currently under investigation by the European Medicines Agency.

AstraZeneca statement

Regarding AstraZeneca, it has issued an official statement, in which it highlights that its research does not show that the Covid-19 vaccine increases the risk of thrombosis. “Analysis of our safety data from more than ten million records shows that there is no evidence of pulmonary embolism or deep vein thrombosis in the specific age group, sex, lot or in any specific country. The risk increases, ”a company spokesman told Europe. News agency.

On Friday, after the World Health Organization (WHO) team of experts ruled out the harm from the AstraZeneca vaccine, it will meet tomorrow to conduct an “in-depth” analysis of the safety of the “AstraZeneca” vaccine.

From the EMA to the statement, he ensures that they continue to study data related to thromboembolic episodes during the weekend. The EMA security committee will continue to review this information and will convene a special meeting on March 18 (Thursday) to summarize the information collected and any further action that may be taken.

AstraZeneca in the spotlight

The AstraZeneca vaccine has been criticized. The first is due to the lack of supply of doses and the second to the suspicion generated by the vaccination of people over 65 years of age.

You may also be interested in:

As a precautionary measure, countries like Spain do not allow vaccination to people over 55 years of age, despite the fact that several autonomous communities require vaccination.

Deja un comentario